Related Experiment Video
Updated: Feb 22, 2026

10:11
Whole-Body Nanoparticle Aerosol Inhalation Exposures
Published on: May 7, 2013
16.3K
Pulmonary Effects from a Simulated Long-Duration Mission in a Confined Cockpit.
Aerospace Medicine and Human Performance
|September 20, 2017
Summary
Sedentary, long-duration missions in confined cockpits significantly reduce pulmonary function. These effects, observed in pilots wearing flight gear, highlight potential operational concerns in similar environments.
Area of Science:
- Aerospace Medicine
- Human Physiology
- Occupational Health
Background:
- A U-2 fatigue study provided data on pulmonary function changes after simulated long-duration missions.
- Subjects experienced 12-hour seated exposures in a hypobaric chamber under two mission configurations.
Purpose of the Study:
- To compare pulmonary function before and after prolonged sedentary exposure in a confined cockpit.
- To assess the impact of different breathing gases (100% oxygen vs. air) and altitudes on pulmonary metrics.
Main Methods:
- Ten subjects underwent simulated missions in a hypobaric chamber.
- Pulmonary function was measured using forced vital capacity, forced expiratory volume in 1 second, peak expiratory flow, and FEV1/FVC ratio.
- Two conditions were tested: full pressure suit with oxygen at 15,000 ft and standard flight gear with air at 8,000 ft.
Main Results:
- Significant declines were observed in all four pulmonary function metrics after 12 hours.
- Declines ranged from 2.7% to 13.9% across the measured parameters.
- These declines occurred irrespective of the breathing gas composition or altitude simulated.
Conclusions:
- Acute, sedentary exposure in confined cockpits leads to measurable pulmonary function decrements.
- The observed pulmonary effects appear independent of oxygen percentage in the breathing gas.
- Findings suggest potential operational implications for missions involving prolonged inactivity in confined environments.
Related Concept Videos
Factors Affecting Pulmonary Ventilation
3.4K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
3.4K
Acute Respiratory Failure-II
1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K
Chronic Obstructive Pulmonary Disease
2.7K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.7K
Pulmonary Cycle: Exhalation
4.1K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K

